| Revenue growth | 15% annual growth, 18% Q4 growth. |
|---|---|
| Margins | B2B margins at 14%; group margins 12-13%. |
| Order book | Good pipeline of projects across sales teams. |
| Demand visibility | Robust orders; agro dependent on El Nino. |
| Management confidence | Bullish on 15%+ growth for FY27. |
Growth
FY26 revenue grew 15% to ₹2,396.4cr; Q4 revenue up 18% YoY to ₹684.9cr. EBITDA grew 8% YoY.
Outlook
Guided for minimum 15% revenue growth in FY27; EBITDA margins 12-13%; ₹50-75cr CAPEX; target debt-free in 18 months.
Risks
Geopolitical volatility in Middle East impacting raw material costs (25-30% spikes) and supply chain logistics.
Earnings Call filed with NSE, NSE: ROSSARI. Summary written with AI assistance from the document.
Rossari Biotech Ltd: key numbers
- Share price
- ₹444.20
- Market cap
- ₹2,461 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 16.3×Sector 37.5×
- Promoter holding
- 68.14%-0.01% QoQ
- FII holding
- 2.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech achieved its highest-ever quarterly revenue of Rs. 697.2 crore and EBITDA of Rs. 80.6 crore in Q1 FY27, driven by 28% YoY top-line growth and international expansion.
- Call
- Guides 15% growth
Rossari Biotech Earnings Call: Key Takeaways
Rossari Biotech reported record Q1 FY27 revenue of Rs. 697.2 cr (up 28.2% YoY) and EBITDA of Rs. 80.6 cr (up 18.7% YoY), driven by strong demand across core HPPC and TSC segments.
Rossari Biotech Earnings Call: Key Takeaways
Rossari Biotech reported highest-ever quarterly revenue of ₹684.9 cr and EBITDA of ₹77.3 cr in Q4 FY26. Performance driven by HPPC segment (77% of revenue) and capacity expansions.
Rossari Biotech Q4 FY26 Results: Net Profit ₹46 Cr, Up 33.7% YoY
Rossari Biotech Ltd reported revenue from operations of ₹684.9 Cr (+18.2% YoY) and net profit of ₹46 Cr (+33.7% YoY) for Q4 FY26.
- Key figure
- Net profit ₹46 Cr · +33.7% YoY